Bakker Juliet Tammenoms

CIK: 0001431159

Transaction Breakdown

Open Market Buys (P)1 (14.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (71.4%)

Compensation grants

Other (G, F, J, C, D, …)1 (14.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

RXST

RxSight, Inc.

Director

CBLL

Ceribell, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

RXST
RxSight, Inc.
Jun 17, 2026
Award(A)
Direct
37K shares-
CBLL
Ceribell, Inc.
Jun 2, 2026
Award(A)
Direct
7.8K shares-
CBLL
Ceribell, Inc.
Jun 10, 2025
Award(A)
Direct
8.8K shares-
RXST
RxSight, Inc.
Jun 3, 2025
Award(A)
Direct
10.8K shares-
CBLL
Ceribell, Inc.
Oct 15, 2024
Conversion(C)
Indirect
2.1M shares-
CBLL
Ceribell, Inc.
Oct 15, 2024
Purchase(P)
Indirect
237.2K shares at avg. $17.00$4.0M
CBLL
Ceribell, Inc.
Oct 11, 2024
Award(A)
Direct
6.6K shares-

		Type	Shares	Price		Ownership
Jun 17, 2026	RXST RxSight, Inc.	Award(A)	37,037	-	$0	Direct
Jun 2, 2026	CBLL Ceribell, Inc.	Award(A)	7,838	-	$0	Direct
Jun 10, 2025	CBLL Ceribell, Inc.	Award(A)	8,828	-	-	Direct
Jun 3, 2025	RXST RxSight, Inc.	Award(A)	10,752	-	-	Direct
Oct 15, 2024	CBLL Ceribell, Inc.	Conversion(C)	2,140,600	-	$0	Indirect
Oct 15, 2024	CBLL Ceribell, Inc.	Purchase(P)	237,234	$17.00	$4,032,978	Indirect
Oct 11, 2024	CBLL Ceribell, Inc.	Award(A)	6,618	-	$0	Direct

1-7 of 7 transactions

About Tammenoms Bakker Juliet

Tammenoms Bakker Juliet (SEC CIK 0001431159) files insider reports with the SEC as Director of RxSight, Inc. (RXST) and Director of Ceribell, Inc. (CBLL).

Signal8 holds 6 ownership filings by Tammenoms Bakker Juliet (1 Form 3, 5 Form 4), filed between Oct 10, 2024 and Jun 18, 2026. Those filings report 7 transactions, from Oct 11, 2024 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Tammenoms Bakker Juliet's filings is in SUNNYVALE, CA.

Recent filings by Tammenoms Bakker Juliet

Jun 17, 2026: Grant or award of RXST shares (Form 4, code A).
Jun 2, 2026: Grant or award of CBLL shares (Form 4, code A).
Jun 10, 2025: Grant or award of CBLL shares (Form 4, code A).
Jun 3, 2025: Grant or award of RXST shares (Form 4, code A).
Oct 15, 2024: Conversion of CBLL shares (Form 4, code C).

Other insiders filing for RxSight, Inc. (RXST)

Weinberg Eric
Wilterding Mark, Chief Financial Officer
Kurtz Ronald M MD, Chief Medical Officer
Goldshleger Ilya, Chief Operating Officer
Mottiwala Aziz, President and CEO
Warner Robert Keith, Director

How to read Form 4 transaction codes